Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients

被引：49
|
作者：
Hermann, M [1 ]
Åsberg, A
Christensen, H
Holdaas, H
Hartmann, A
Reubsaet, JLE
机构：
[1] Univ Oslo, Sch Pharm, Dept Pharmacol, Oslo, Norway
[2] Natl Hosp, Dept Med, Lab Renal Physiol, Oslo, Norway
[3] Univ Oslo, Sch Pharm, Dept Pharmaceut Anal, Oslo, Norway
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 76卷 / 04期
关键词：
D O I：
10.1016/j.clpt.2004.07.008
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：388 / 391
页数：4
相关论文
共 50 条
  • [41] EFFECT OF FELODIPINE ON RENAL HEMODYNAMICS AND TUBULAR SODIUM HANDLING IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    SORENSEN, SS
    SKOVBON, H
    EISKJAER, H
    THOMSEN, K
    PEDERSEN, EB
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (01) : 69 - 78
  • [42] SYSTEMIC BUT NOT RENAL PRODUCTION OF PROSTACYCLIN IS HIGHLY REDUCED IN CYCLOSPORINE-TREATED HEART-TRANSPLANT RECIPIENTS
    BORDET, JC
    DELORGERIL, M
    DURBIN, S
    BOISSONNAT, P
    RENAUD, S
    DUREAU, G
    DECHAVANNE, M
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (05): : 486 - 487
  • [43] Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients
    Chang, H. R.
    Lin, C. C.
    Lian, J. D.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) : 3135 - 3141
  • [44] CLINICAL AND IMMUNOLOGICAL FEATURES OF CYTOMEGALOVIRUS-INFECTION IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    BRANDO, B
    CIVATI, G
    BUSNACH, G
    BROGGI, ML
    BELLI, LS
    SEVESO, M
    BRUNATI, C
    MINETTI, L
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (06) : 2683 - 2685
  • [45] IMMUNOPHARMACODYNAMIC EVALUATION OF CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS
    ROGERS, AJ
    YOSHIMURA, N
    KERMAN, RH
    KAHAN, BD
    TRANSPLANTATION, 1984, 38 (06) : 657 - 664
  • [46] COMPLETE REPLACEMENT OF METHYLPREDNISOLONE BY AZATHIOPRINE IN CYCLOSPORINE-TREATED PRIMARY CADAVERIC RENAL-TRANSPLANT RECIPIENTS
    KUPIN, W
    VENKAT, KK
    OH, HK
    DIENST, S
    TRANSPLANTATION, 1988, 45 (01) : 53 - 55
  • [47] CORTICOSTEROID WITHDRAWAL WITH SUBSTITUTION OF AZATHIOPRINE IN CYCLOSPORINE-TREATED PRIMARY CADAVERIC RENAL-TRANSPLANT RECIPIENTS
    KUPIN, W
    VENKAT, KK
    FLORENCEGREEN, D
    NORRIS, C
    OH, HK
    DIENST, S
    LEVIN, NW
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 2024 - 2026
  • [48] T-SUPPRESSOR CELL-FUNCTION IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    BRANDO, B
    CIVATI, G
    BUSNACH, G
    GRILLO, C
    MINETTI, L
    TRANSPLANTATION PROCEEDINGS, 1984, 16 (06) : 1639 - 1641
  • [49] RENAL VASCONSTRICTION IN CYCLOSPORINE-TREATED (CY) TRANSPLANT RECIPIENTS (TXR) WITHOUT OTHER EVIDENCE OF NEPHROTOXICITY
    CURTIS, JJ
    LUKE, RG
    JONES, P
    DUBOVSKY, EV
    WHELCHEL, JD
    DIETHELM, AG
    KIDNEY INTERNATIONAL, 1986, 29 (01) : 428 - 428
  • [50] Endothelin-1 plasma levels in cyclosporine-treated stable renal transplant patients
    Costa, C
    Cauduro, RL
    Lhulier, F
    Cabral, RD
    Garcia, RG
    Manfro, RC
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (02) : 487 - 488
12345